Newsroom

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast tomorrow at 8 a.m. EDT to discuss topline results from Emerge, its first randomized, double-blind, placebo-controlled Phase 3 study evaluating a single dose of DT120 ODT 100 µg in adults with...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) is pleased to announce that new three-year collective bargaining agreements have been ratified with both unions at the Mantos Blancos Mine in Chile within the legal timeframe established. Following successful negotiation of agreements that support our employees and the long-term sustainability of the operation, Mantos Blancos will continue to focus on safe and responsible mining...

SAN DIEGO--(BUSINESS WIRE)--The case alleges Roblox and certain of its top executives made false and/or misleading statements to investors....

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of directors and scientific advisory board. The expansion brings Syntax Bio’s Series A to $14.4 million and total funding to over $25 million. The expanded round builds on support from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Ventures, EGB Capital, Mansu...

SAN DIEGO--(BUSINESS WIRE)--The case alleges ADMA Biologics and certain of its executives made false and/or misleading statements to investors....

SAN FRANCISCO--(BUSINESS WIRE)--Andersen Global indgår en samarbejdsaftale med JMP Advisors i Indien og tilføjer skattemæssig ekspertise til virksomhedens eksisterende juridiske kapaciteter i landet. JMP Advisors tilbyder rådgivning inden for skat, lovgivning og transaktioner til både nationale og multinationale klienter, der opererer i komplekse forretningsmiljøer i konstant udvikling. Firmaet leverer ydelser, der spænder over international og indisk skat, transfer pricing, international struk...

MILANO--(BUSINESS WIRE)--WISE S.p.A., azienda innovativa di dispositivi medici specializzata in elettrodi impiantabili all'avanguardia per il neuromonitoraggio, la neuromodulazione e le interfacce cervello-computer (BCI, Brain-Computer Interface), oggi ha annunciato la chiusura di un round di finanziamento di serie D sottoscritto in eccesso, per un totale di 30 milioni di euro. Al round ha partecipato anche ENEA Tech and Biomedical, una fondazione italiana dedicata all'innovazione e al trasferi...

MILAN--(BUSINESS WIRE)--WISE S.p.A., société pionnière dans le domaine des dispositifs médicaux et spécialisée dans les électrodes implantables de pointe utilisés pour le neuromonitoring, la neuromodulation et les interfaces cerveau-ordinateur (ICO), a annoncé aujourd'hui la clôture réussie d'un tour de table de série D sursouscrit, d'un montant total de 30 millions d'euros. ENEA Tech and Biomedical, une fondation italienne dédiée à l'innovation et au transfert de technologies dans le secteur b...

MILAAN--(BUSINESS WIRE)--WISE S.p.A., een toonaangevend bedrijf op het gebied van medische hulpmiddelen dat gespecialiseerd is in geavanceerde implanteerbare elektroden voor neuromonitoring, neuromodulatie en hersen-computerinterfaces (BCI), heeft vandaag bekendgemaakt dat de overtekende Serie D-financieringsronde met een totaalbedrag van 30 miljoen euro succesvol is afgerond. Aan deze ronde nam ENEA Tech e Biomedical deel. Dit is een Italiaanse stichting die zich toelegt op innovatie en techno...

MAILAND--(BUSINESS WIRE)--WISE S.p.A., ein wegweisendes Medizintechnikunternehmen, das sich auf fortschrittliche implantierbare Elektroden für Neuromonitoring, Neuromodulation und Gehirn-Computer-Schnittstellen (BCI) spezialisiert hat, gab heute den erfolgreichen Abschluss einer überzeichneten Serie-D-Finanzierungsrunde in Höhe von insgesamt 30 Millionen Euro bekannt. An der Runde beteiligte sich ENEA Tech and Biomedical, eine italienische Stiftung, die sich der Innovation und dem Technologietr...